Sagimet Biosciences’ Post
More Relevant Posts
-
Join Sagimet Biosciences (#SGMT) for a conference call and webcast on Thurs. June 13 at 12:30pm ET featuring Rohit Loomba, M.D., M.H.Sc., (MASLD Research Center, University of California San Diego), to discuss positive data from the FASCINATE-2 Phase 2b clinical trial of denifanstat versus placebo in biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. Attend: https://lnkd.in/g6v4DdAb
To view or add a comment, sign in
-
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024 Press Release: https://lnkd.in/gWFhiskW Presentation: https://lnkd.in/gZDt4Csw
To view or add a comment, sign in
-
Join Sagimet Biosciences (#SGMT) for a virtual investor and analyst day on Thurs. May 23 at 1:00pm ET featuring Scott L. Friedman, MD (Icahn School of Medicine at Mount Sinai), who will discuss the unmet need and current treatment landscape for patients with metabolic dysfunction-associated steatohepatitis #MASH. Register here: https://lnkd.in/g46Pa7Jy
To view or add a comment, sign in
-
Sagimet Biosciences’ first quarter 2024 financial results and corporate updates are now available: https://lnkd.in/ed5MKm_P #biotech #NASH #denifanstat #FASN #FASCINATE2 $SGMT
To view or add a comment, sign in
-
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer. Learn more here: https://lnkd.in/gp32f3Sn
To view or add a comment, sign in
-
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors. Learn more here: https://lnkd.in/gFavsWPF
To view or add a comment, sign in
-
Sagimet Biosciences’ fourth quarter and full year 2023 financial results and corporate updates are now available: https://lnkd.in/gUeJm35v
To view or add a comment, sign in
-
Next month, management will participate in two investor conferences. Learn more about how to access the webcasts and archived replays: https://lnkd.in/g2-U6nfm #biotech #NASH #denifanstat #TDCowenHealthCare #LeerinkPartners
To view or add a comment, sign in
-
Sagimet Biosciences announced pricing of a public offering of $112.5 M Series A common stock. Read more: https://lnkd.in/gJt5NUPy
To view or add a comment, sign in
2,946 followers